arrow_back Back to App

Medicare: Testing Coverage for Low Vision Devices

This act establishes a five-year Medicare pilot program to evaluate the financial impact of covering specialized low vision devices. The goal is to determine if these devices should be permanently covered, potentially improving access to essential visual aids for many citizens.
Key points
Medicare will begin testing coverage for low vision devices, such as magnifiers or image enhancers, which are not ordinary eyeglasses.
The program will run for 5 years nationwide, aiming to assess the financial impact on the insurance system.
Participants must have a prescription from an ophthalmologist or optometrist certifying medical necessity for the device.
Results will help decide if these devices become permanent Medicare benefits, potentially improving the quality of life for individuals with severe vision impairment.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6848
Sponsor: Rep. Maloney, Carolyn B. [D-NY-12]
Process start date: 2022-02-25